Kowa’s entry into the U.S. pharmaceutical market in 2008 represented a significant step towards the Japanese company’s vision of creating a global pharmaceutical organization. Kowa Pharmaceuticals America (KPA) is primarily focused on cardiometabolic therapeutics. As their business model got more complex, sales leadership sought to maximize sales operations efficiency with an approach that goes beyond software. In October 2014, Kowa’s high-level relationship with sales Performance Management as a Service™ emerged.

Based on Synygy’s 25 years of pharma sales compensation experience, this agile approach helps Kowa sales teams to calibrate their performance with the help of fast, actionable information they use in real time to seize opportunities. In just two weeks after starting the relationship with Synygy’s SPMaaS™, Kowa started to take immediate corrective actions for Q3 and Q4 to increase sales performance and drive desired behaviors across sales force.

Read this case study to learn more about how Synygy’s innovative approach proved to be the best solution for Kowa’s complex operations in the pharmaceutical industry.